Literature DB >> 17977076

ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis.

Henrik S Thomsen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977076     DOI: 10.1007/s00330-007-0744-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


× No keyword cloud information.
  15 in total

1.  Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-02-23       Impact factor: 17.586

2.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

3.  Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?

Authors:  S K Morcos
Journal:  Br J Radiol       Date:  2007-03-28       Impact factor: 3.039

4.  Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned.

Authors:  Dale R Broome; Mark S Girguis; Pedro W Baron; Alfred C Cottrell; Ingrid Kjellin; Gerald A Kirk
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

5.  Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update.

Authors:  M Maloo; P Abt; R Kashyap; D Younan; M Zand; M Orloff; A Jain; A Pentland; G Scott; A Bozorgzadeh
Journal:  Am J Transplant       Date:  2006-06-19       Impact factor: 8.086

6.  Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.

Authors:  Whitney A High; Reed A Ayers; John Chandler; Gary Zito; Shawn E Cowper
Journal:  J Am Acad Dermatol       Date:  2006-11-09       Impact factor: 11.527

Review 7.  In which patients should serum creatinine be measured before iodinated contrast medium administration?

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

8.  Gadolinium-containing contrast media for radiographic examinations: a position paper.

Authors:  Henrik S Thomsen; Torsten Almèn; Sameh K Morcos
Journal:  Eur Radiol       Date:  2002-08-16       Impact factor: 5.315

9.  Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.

Authors:  Aneet Deo; Mitchell Fogel; Shawn E Cowper
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-07       Impact factor: 8.237

10.  Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2006-10-24       Impact factor: 5.315

View more
  33 in total

Review 1.  ESUR guidelines: ovarian cancer staging and follow-up.

Authors:  Rosemarie Forstner; Evis Sala; Karen Kinkel; John A Spencer
Journal:  Eur Radiol       Date:  2010-09-14       Impact factor: 5.315

2.  MRI-guided percutaneous nephrostomy: a feasibility study.

Authors:  Juho Kariniemi; Roberto Blanco Sequeiros; Risto Ojala; Osmo Tervonen
Journal:  Eur Radiol       Date:  2008-11-26       Impact factor: 5.315

Review 3.  Assessment of vascular disorders of the upper extremity with contrast-enhanced magnetic resonance angiography: pictorial review.

Authors:  Ahmed A K A Razek; Ehab Saad; Nermin Soliman; Heba A Elatta
Journal:  Jpn J Radiol       Date:  2010-02-26       Impact factor: 2.374

4.  [Tumours of the Kidney: CT vs. MRI. Nearly equal alternatives with minor differences].

Authors:  J Huber; P Hallscheidt; N Wagener; S Pahernik; A Haferkamp; M Hohenfellner
Journal:  Urologe A       Date:  2010-03       Impact factor: 0.639

Review 5.  Neonatal cardiac imaging.

Authors:  Rajesh Krishnamurthy
Journal:  Pediatr Radiol       Date:  2010-04

6.  Significant differences when using MDRD for GFR estimation compared to radionuclide measured clearance.

Authors:  A J Craig; A Britten; S D Heenan; A G Irwin
Journal:  Eur Radiol       Date:  2011-05-21       Impact factor: 5.315

7.  25th Anniversary of European Radiology.

Authors:  Maximilian F Reiser
Journal:  Eur Radiol       Date:  2017-01       Impact factor: 5.315

8.  [Contrast agents in radiology: current agents approved, recommendations, and safety aspects].

Authors:  P Reimer; R Vosshenrich
Journal:  Radiologe       Date:  2013-02       Impact factor: 0.635

Review 9.  MR imaging of aortic coarctation.

Authors:  F Secchi; A Iozzelli; G D E Papini; A Aliprandi; G Di Leo; F Sardanelli
Journal:  Radiol Med       Date:  2009-05-14       Impact factor: 3.469

10.  Different imaging strategies in febrile urinary tract infection in childhood. What, when, why?

Authors:  Diego De Palma; Gianantonio Manzoni
Journal:  Pediatr Radiol       Date:  2013-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.